ACR Convergence 2023| ANCA-Associated Vasculitis| Psoriatic Arthritis

An official publication of the ACR and the ARP serving rheumatologists and rheumatolgy professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • ACR Open Rheumatology
    • Arthritis & Rheumatology
    • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Immunology Insights for the Rheumatologist

Keri Losavio  |  Issue: November 2023  |  October 10, 2023

“Immunology in particular is the underlying basis for the science of rheumatology,” says Richard Bucala, MD, PhD, chief of rheumatology, allergy and immunology, Yale School of Medicine, New Haven, Conn. “However, the expansion in our immunology knowledge base, together with the increasing role of immune-targeted therapies, can challenge rheumatologists, who struggle to keep up with evolving knowledge.”

This knowledge explosion is the impetus behind a new review series in Arthritis & Rheumatology (A&R). The goal: Improve readers’ understanding of immunology and its latest advances, aiming to provide concise, practical knowledge for all rheumatologists.

“This isn’t simplified immunology for trainees,” says Dr. Bucala. “It’s for everyone. It’s practical, up to date and will fill knowledge gaps. It’s for seasoned practitioners and physician-scientists alike,” he emphasizes.

Dr. Bucala, the immediate past editor in chief of A&R, and current Editor-in-Chief Daniel H. Solomon, MD, MPH, introduced the new series in an article posted first online in October.1 “The reviews will provide state-of-the-art information but will strive to be concise and focused on practical questions in diagnosis or management raised by particular clinical scenarios,” they wrote.

The Complement System

Adobe Stock / Creative Vault

First up, Paul A. Monach, MD, PhD, reviews complement biology in the context of interpreting complement values in a suspected case of immune complex vasculitis.2

Setting a tone of accessibility and practicality for a complex topic, Dr. Monach starts his review of the complement system with a case presentation, which establishes the scientific question being addressed: “You are asked to evaluate a 53-year-old woman with recent onset palpable purpura of both lower legs. …” He then offers a high-level overview of the complement system.

“As with other aspects of innate immunity, the complement system has evolved to interact with the adaptive immune system to facilitate the anti-microbial effectiveness of immunoglobulins while retaining pathways for direct recognition of microbial structures,” writes Dr. Monach.

Clinicians will benefit from the callouts in the review article specifically designed to deliver information they can use in practice. Example: “A ‘bottom line up front’ message for clinicians is that a low level of circulating C3 or C4 is always abnormal (subject to the usual caveat that reference ranges are arbitrarily defined to cover 95% of the population) and is usually but not always indicative of a disease state, especially for C3. However, the disease states that deplete C4 are less diverse than those that deplete C3,” the article notes.

Page: 1 2 | Single Page
Share: 

Filed under:American College of RheumatologyResearch Reviews Tagged with:Arthritis & RheumatologycomplementImmunology

Related Articles
    Lost and found

    A Look Back at the First Use of Cortisone in Rheumatoid Arthritis

    January 17, 2023

    In 1949, the first description of patients with rheumatoid arthritis (RA) given cortisone sent shockwaves through the medical community, quickly capturing the public imagination as well. The paradigm-shifting report paved the way for the use of cortisone and related drugs in RA and many other medical conditions.1 The following is a discussion of some of…

    Exploring the Complement System in Human Disease

    February 1, 2010

    Novel disease associations revealed by whole genome screens

    COVID-19, New Research & More: 2 Experts Discuss Scientific Advances in Rheumatology at ACR Convergence 2020

    September 14, 2020

    The Year in Review session during ACR Convergence 2020 will address advances in clinical and basic science related to rheumatology, including drug safety, precision medicine, the COVID-19 pandemic and more.

    Predatory Publishing: Know the Difference Between a Financial Scheme and Scholarly Dissemination

    December 20, 2017

    It happens every day. A new email pops up in a researcher’s in-box from a journal with a seemingly familiar name and an invitation to publish a research paper, present at a meeting or, perhaps, serve on an editorial board. Like many of her colleagues, Marian Hannan, DSc, MPH, professor of medicine at Harvard Medical…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2000-2023 American College of Rheumatology. All rights reserved. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences